2015-3-20-fda-cole-garrett-final-paper.pdf
TRANSCRIPT
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
1/13
G E D C C
E (E) ,
. 132
. ,
2006.
.
.
,
. E
.
, , .
1950 132
. 2006 D .
.
370. . A
F 1 F 2.
.
1
C
132
132
D
132/33
1.6
19.1
34.8 19.1
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
2/13
132
D .
2005 2012 1.
85 33 55
. 85 , 79 ( ) 6
( ). 2012 D . F
D
.
E 33 D
20,000 .
1
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
3/13
2005 3 C
2006 2
1 C
1 C
2007 1 C
2 C 1 1
2008 3
C
6
A
C
2009 2
10 A C 2 2010 9 F 1 8
13
4
C
1 D E
2011 1 F C
10
C
2
D
2012 4
F
1 3
10
A
C
1 00 01
E .
.
F 3 G1 G2 .
4 6 .
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
4/13
F 4
. G1
6
0
2
4
6
8
10
12
14
0 2 2 4 4 6 6 8 8 10
0
2
4
6
8
10
12
14
F A
. .
. A
. F 5
.
0
12
12
14
14
16
16
18
18
20
20
22
22
24
2004
2006
2008
2010
2012
A D
1
2004
2005
2006
2007
2008
2009
2010
2011
2012
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
5/13
E
0
0.5
1
1.5
2
2.5
3
3.5
4
F
A
0
0.5
1
1.5
2
1
1
50%
:
2004
2007
2010
D
200
200
200
200
200
200
201
201
201
2004
2007
2010
2
2
2
2
2
2
2
2
2
.
004
005
006
007
008
009
010
011
012
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
6/13
.
. .
D
.
.
.
.
B
( ) 2006
2 D. .
, , ,
. H,
.
D
.
2004, , E
. .
.
:
A 2009
. H,
, .
E 132 .
F 2010.
. E
(
) .
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
7/13
A 2012 E
.
.
2013 7 .
, , .
2013 H
D
/ .
E
2014 . .
B 2012 . ,
, 132
. D
H D, .
A 2013 2014. F 7
.
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
8/13
.
.
2013 .
.
.
() ,
. ,
, D.
C .
.
.
. H,
D
. D
. F 8 14
2006 .
. 55.5. 53.9.
300 F 1.
F 9.
D
6,000 GB
.
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
9/13
E D
H .
, ,
2013 . A 132/33 D
00
00
C 19.38
34.5
53.9
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
10/13
. 10.
F 11 18 2013 D
. A
19.21 D
.
.
10
11
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
11/13
D
.
5
D 2013 G1 9
. F 12 . 2
.
2014 D .
14 23.02. () G1
1 D D
F 13.
1
01
1
1
1
01
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
12/13
17
23.02 () G2 .
D.
D, 2.
( ) 17.91 .
17.91
. 1 D.
B
.
.
D
E ,
. . A
.
. H
.
-
7/26/2019 2015-3-20-FDA-Cole-Garrett-Final-paper.pdf
13/13
E E E
D C. H H
BCC C
. H ,
, . H
A . D E
.
C E. A E E E
, . H
E EEE E
D.